Europe authorised deutetrabenazine only in January 2026, and no official price list carries it yet. Here is what 30 days cost in the US at each dose.
Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →
Austedo XR (deutetrabenazine) is one extended-release tablet a day for chorea in Huntington’s disease or tardive dyskinesia; the dose starts at 12 mg and rises by 6 mg a week to at most 48 mg (FDA label) — so 30 days = 30 tablets of one strength. We show three common doses. US prices only: no European official price list carries deutetrabenazine yet. The price types differ — list price, negotiated price, pharmacy acquisition cost — and are labelled.
AUSTEDO XR (DEUTETRABENAZINE) · 30 DAYS = 30 TABLETS, BY DOSE
US price by dose, November 2026
No European official price yet (EU authorisation January 8, 2026).
| Country | Official price | 30 days in US dollars | What a patient typically pays |
|---|---|---|---|
| 🇺🇸 United States (list, 2024) | Austedo / Austedo XR $6,623 for a 30-day supply (CMS, 2024) | $6,623 | More than 90% of patients pay $10 or less a month (maker’s figure); commercially insured may pay $0 |
| 🇺🇸 United States (pharmacy cost, 12 mg) | Austedo XR 12 mg $166.94247 per tablet (CMS NADAC, Nov 4, 2026) | $5,008 | — |
| 🇺🇸 United States (pharmacy cost, 24 mg) | Austedo XR 24 mg $250.31683 per tablet (CMS NADAC) | $7,510 | — |
| 🇺🇸 United States (pharmacy cost, 48 mg) | Austedo XR 48 mg $502.54557 per tablet (CMS NADAC) | $15,076 | — |
| 🇺🇸 United States (Medicare, 2027) | $4,093 negotiated price per 30-day supply, from Jan 1, 2027 (CMS); per XR tablet $100.542539 (12 mg), $150.813809 (24 mg), $301.623098 (48 mg) | $3,016 / $4,524 / $9,049 | Extra Help enrollees typically pay about $12.15 a month (maker’s figure) |
| 🇬🇧 United Kingdom | Not listed in the NHS dictionary of medicines (dm+d) | — | — |
| 🇫🇷 France | No deutetrabenazine product in the public medicines database | — | — |
| 🇨🇭 Switzerland | Not in the Spezialitätenliste | — | — |
| 🇦🇹 Austria | Not in the reimbursement code (November 2026) | — | — |
| 🇳🇱 Netherlands | Not listed on Medicijnkosten.nl (to November 1, 2026) | — | — |
| 🇩🇪 Germany | No statutory price ceiling (Festbetrag); EU authorisation since January 8, 2026 | — | — |
We compare prices; we do not recommend where to buy medicine. Dose changes for movement disorders are a decision for your doctor.
The $4,093 is the price Medicare negotiated for Austedo and Austedo XR under the Inflation Reduction Act for a 30-day supply, effective January 1, 2027. CMS’s data file sets a price for each tablet strength — for Austedo XR, $100.542539 at 12 mg, $150.813809 at 24 mg and $301.623098 at 48 mg, or $3,016, $4,524 and $9,049 for 30 tablets (our calculation). In 2024 about 27,000 people with Medicare Part D used Austedo, and Part D spent $1.68 billion on it before rebates (CMS).
Teva’s own price sheet still shows its list prices as of January 1, 2025: $5,003.00 for 30 XR tablets of 12 mg, $7,504.40 at 24 mg and $15,008.90 at 48 mg. US pharmacies paid almost exactly that in November 2026 (CMS NADAC). Teva says more than 90% of people taking Austedo pay $10 or less a month, that commercially insured patients may pay $0, and that Medicare enrollees with Extra Help typically pay about $12.15.
The European Commission authorised Austedo on January 8, 2026, as prolonged-release tablets for adults with moderate to severe tardive dyskinesia — not for Huntington’s chorea (EMA). As of November 2026, none of the UK, French, Swiss, Austrian, Dutch and German official lists we checked includes it, and Germany has no Festbetrag for it.
CMS recorded a list price of $6,623 for a 30-day supply in 2024, and Medicare’s negotiated price from January 1, 2027 is $4,093 (CMS). What a month costs depends on the dose: US pharmacies paid about $5,008 for 30 Austedo XR tablets of 12 mg, $7,510 at 24 mg and $15,076 at 48 mg in November 2026 (CMS NADAC).
There is no official price yet. The EU authorised Austedo on January 8, 2026, for tardive dyskinesia (EMA), but the UK, French, Swiss, Austrian, Dutch and German price lists did not include it as of November 2026.
Mostly yes, roughly in proportion to the dose — but 18 mg and 24 mg tablets cost practically the same, and so do 42 mg and 48 mg (Teva list prices, CMS NADAC, CMS data file).
Teva says more than 90% of people taking Austedo pay $10 or less a month; commercially insured patients may pay $0 with its co-pay program, and Medicare enrollees with Extra Help typically pay about $12.15 a month (maker’s figures, January 2025).
Not in the US pharmacy price survey (NADAC, November 4, 2026), which lists only Austedo and Austedo XR; CMS negotiates only drugs without generic competition.
Wellness Vision does not sell medicine, recommend pharmacies or suppliers, or take payments from drug makers. Every price above comes from the official source cited; currency conversions and 30-day figures are our own calculations, shown with their formula. This is a cost comparison, not medical advice.
You shouldn't have to go broke to feel whole.
